RecruitingNCT05285735
Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants
Sponsor
Amivas Inc.
Enrollment
25 participants
Start Date
Jun 8, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
This study is a prospective observational study in which a female patient who received IV Artesunate while pregnant can volunteer to provide information about her pregnancy and the outcome of her pregnancy. Information will be collected from patient's provider, the patient's obstetrician, the child's pediatrician, or other relevant healthcare provider.
Eligibility
Sex: FEMALEMin Age: 15 YearsMax Age: 100 Years
Inclusion Criteria4
- Patient received IV Artesunate
- Patient was pregnant while receiving IV Artesunate
- Patient was at least 15 years of age
- Patient or legal guardian/representative gave consent for the study and to collect data from her physicians
Exclusion Criteria1
- None
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05285735
Related Trials
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
NCT039378171 location
PREgnancy and FERtility Registry
NCT0289516523 locations
Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia
NCT029890251 location
MitoQ to Improve Vascular Funciton in Preeclampsia
NCT072292611 location
Probiotic Supplementation in Optimizing Iron and Hematological Status Among Pregnant Females
NCT070768491 location